Michael Verlander, D.Phil

​

Michael Verlander, D.Phil currently serves as the Senior Vice President for CMC and Quality Assurance at Nuvie Bio.

 

Michael has over 40 years of industry experience in leadership roles in research and development, quality assurance and compliance, and CMC and regulatory affairs in the synthetic peptide manufacturing industry.

 

Most recently, he has served as an independent consultant supporting the pharmaceutical industry in the areas of product development and quality and regulatory compliance, as well as a member of USP’s Biologics Monographs-1 Peptides and Oligonucleotides Expert Committee. 

 

Prior to this, Michael was a Co-founder of the PolyPeptide Group, a leading contract manufacturer of synthetic peptide APIs, where he most recently served as President of the group’s San Diego facility and, prior to this, as Global Director of Quality Assurance and Regulatory Affairs and Executive Vice President, Quality Assurance and Regulatory Affairs at the group’s Torrance facility. 

 

Prior to his tenure at the Polypeptide Group, he served as Vice President and member of the executive management team at Bachem California.

 

Michael earned his D.Phil in organic chemistry from the University of Oxford, UK, and completed post-doctoral research in chemistry at the Salk Institute, La Jolla, CA.